Pharmacokinetics and bioequivalence of Ezetimibe tablet versus Ezetrol®:an open-label, randomized, two-sequence crossover study in healthy Chinese subjects

BACKGROUND: Ezetimibe is a new class of antihyperlipidemic agent indicated for the prevention of atherosclerosis disease and for the treatment of hypercholesterolemia. Information on the pharmacokinetic profiles of ezetimibe tablet in healthy Chinese volunteers are lacking, and regulatory requiremen...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Feifei, Liu, Yanping, Li, Ting, Lin, Pingping, Jiang, Xin, Li, Xin, Wang, Chenjing, Gao, Xiaomeng, Ma, Yaping, Fu, Yao, Cao, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896679/
https://www.ncbi.nlm.nih.gov/pubmed/36737825
http://dx.doi.org/10.1186/s40360-023-00649-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896679/
https://www.ncbi.nlm.nih.gov/pubmed/36737825
http://dx.doi.org/10.1186/s40360-023-00649-y

Ejemplares similares